Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Can Ozlu

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The Protein Journal|February 9, 2025
Low-dose Bee Venom as a Potential Therapeutic Agent Against Human Chronic Myeloid Leukaemia CellsHamza Halici, Harun Un, Saffet Celik, et al.
Muscle & Nerve|June 10, 2026
Two Patients With Juvenile-Onset, Rapidly Progressive Amyotrophic Lateral Sclerosis Associated With an SOD1 Variant (p.Asp125Gly) With Incomplete PenetranceCan Ozlu, Abigail Schwaede, Bridget McGowan, et al.
Gene|July 7, 2012
MDR1 single nucleotide polymorphism C3435T in Turkish patients with non-small-cell lung cancerGamze Gokoz Dogu, Aysegul Kargi, Sebahat Turgut, et al.
Epilepsy Research|December 24, 2025
SLC13A5 citrate transporter disorder epilepsy phenotypeCan Ozlu, Emily M Spelbrink, Tanya L Brown, et al.
Molecular Cell|March 9, 2019
CHP1 Regulates Compartmentalized Glycerolipid Synthesis by Activating GPAT4Xiphias Ge Zhu, Shirony Nicholson Puthenveedu, Yihui Shen, et al.
Genes|October 26, 2024
Sleep Abnormalities in SLC13A5 Citrate Transporter DisorderRaegan M Adams, Can Ozlu, Lauren E Bailey, et al.
Developmental Medicine and Child Neurology|December 22, 2024
Developmental phenotype and quality of life in SLC13A5 citrate transporter disorderCan Ozlu, Raegan M Adams, Rayann M Solidum, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Protein Journal|February 9, 2025
Low-dose Bee Venom as a Potential Therapeutic Agent Against Human Chronic Myeloid Leukaemia CellsHamza Halici, Harun Un, Saffet Celik, et al.
Muscle & Nerve|June 10, 2026
Two Patients With Juvenile-Onset, Rapidly Progressive Amyotrophic Lateral Sclerosis Associated With an SOD1 Variant (p.Asp125Gly) With Incomplete PenetranceCan Ozlu, Abigail Schwaede, Bridget McGowan, et al.
Gene|July 7, 2012
MDR1 single nucleotide polymorphism C3435T in Turkish patients with non-small-cell lung cancerGamze Gokoz Dogu, Aysegul Kargi, Sebahat Turgut, et al.
Epilepsy Research|December 24, 2025
SLC13A5 citrate transporter disorder epilepsy phenotypeCan Ozlu, Emily M Spelbrink, Tanya L Brown, et al.
Molecular Cell|March 9, 2019
CHP1 Regulates Compartmentalized Glycerolipid Synthesis by Activating GPAT4Xiphias Ge Zhu, Shirony Nicholson Puthenveedu, Yihui Shen, et al.
Genes|October 26, 2024
Sleep Abnormalities in SLC13A5 Citrate Transporter DisorderRaegan M Adams, Can Ozlu, Lauren E Bailey, et al.
Developmental Medicine and Child Neurology|December 22, 2024
Developmental phenotype and quality of life in SLC13A5 citrate transporter disorderCan Ozlu, Raegan M Adams, Rayann M Solidum, et al.
Pageof 2